United States Neuromodulation Market PPT: Growth, Outlook, Demand, Keyplayer Analysis and Opportunity 2024-32

1
United States Neuromodulation Market Research and
Forecast Report 2024-2032

• Format PDFEXCEL

2023 IMARC All Rights Reserved
2
About IMARC Group

• International Market Analysis Research and
  Consulting Group is a leading adviser on
  management strategy and market research
  worldwide. We partner with clients in all regions
  and industry verticals to identify their
  highest-value opportunities, address their most
  critical challenges, and transform their
  businesses.
• IMARCs information products include major
  market, scientific, economic and technological
  developments for business leaders in
  pharmaceutical, industrial, and high technology
  organizations. Market forecasts and industry
  analysis for biotechnology, advanced materials,
  chemicals, food and beverage, travel and tourism,
  nanotechnology and novel processing methods are
  at the top of the companys expertise.
• IMARCs tailored approach combines unfathomable
  insight into the dynamics of companies and
  markets with close cooperation at all levels of
  the client organization. This ensures that our
  clients achieve unmatchable competitive
  advantage, build more proficient organizations,
  and secure lasting results.

3
Report Highlight and Description

• According to the latest report by IMARC Group,
  titled "United States Neuromodulation Market
  Industry Trends, Share, Size, Growth, Opportunity
  and Forecast 2024-2032," the United States
  neuromodulation market size is projected to
  exhibit a growth rate (CAGR) of 11.50 during
  2024-2032.
• The United States neuromodulation market is
  experiencing significant growth, primarily driven
  by technological advancements in neuromodulation
  devices. In addition to this, the increasing
  prevalence of chronic conditions such as chronic
  pain, epilepsy, and Parkinson's disease is
  further propelling the market growth.
• These conditions are often resistant to
  conventional medical treatments, making
  neuromodulation a vital alternative for effective
  management. Besides this, the growing awareness
  of the potential benefits of neuromodulation
  therapies, including spinal cord stimulation
  (SCS) and deep brain stimulation (DBS), which
  offer significant relief for patients with
  chronic pain and movement disorders is acting as
  another significant factor in the market growth.
• Request for a PDF sample of this report
  https//www.imarcgroup.com/united-states-neuromodu
  lation-market/requestsample

4
Report Description

• United States Neuromodulation Market Trends
• Furthermore, the rising geriatric population in
  the U.S., which is more susceptible to
  neurological disorders, is augmenting the United
  States neuromodulation market. This demographic
  shift is leading to a higher demand for advanced
  and minimally invasive treatments, propelling the
  neuromodulation market forward. Additionally, the
  increasing investment in RD activities by key
  players in the neuromodulation space which leads
  to the introduction of innovative and more
  effective products is creating a positive outlook
  for the market.
• The growing understanding of the human
  neurological system and how it might be
  controlled for therapeutic reasons opens up new
  paths for therapy. Besides this, the
  implementation of supportive government policies
  and the availability of favorable reimbursement
  scenarios, are further accelerating the growth of
  the neuromodulation market in the United States.
  Moreover, the ongoing advancements and the
  increasing adoption of novel therapies, are
  anticipated to boost the United States
  neuromodulation market in the coming years.
• View Report TOC, Figures and Tables
  https//www.imarcgroup.com/united-states-neuromodu
  lation-market

5
Report Segmentation

• Technology Insights
• Internal Neuromodulation
• Spinal Cord Stimulation (SCS)
• Deep Brain Stimulation (DBS)
• Vagus Nerve Stimulation (VNS)
• Sacral Nerve Stimulation (SNS)
• Gastric Electrical Stimulation (GES)
• External Neuromodulation
• Transcutaneous Electrical Nerve Stimulation
  (TENS)
• Transcranial Magnetic Stimulation (TMS)
• Others
•  
• Biomaterial Insights
• Metallic Biomaterials
• Polymeric Biomaterials

6
Report Segmentation

• Ceramic Biomaterials
• Application Insights
• Parkinson's Disease
• Epilepsy
• Depression
• Dystonia
• Pain Management
• Others
• Regional Insights
• Northeast
• Midwest
• South
• West

7
Key Questions Answered in the Report
8
Table of Contents

• 1    Preface2    Scope and Methodology    2.1  
   Objectives of the Study    2.2  
   Stakeholders    2.3    Data Sources       
  2.3.1    Primary Sources        2.3.2  
   Secondary Sources    2.4    Market Estimation 
        2.4.1    Bottom-Up Approach        2.4.2  
   Top-Down Approach    2.5    Forecasting
  Methodology3    Executive Summary4     United
  States Neuromodulation Market - Introduction   
  4.1    Overview    4.2    Market Dynamics   
  4.3    Industry Trends    4.4    Competitive
  Intelligence5   United States Neuromodulation
  Market Landscape    5.1    Historical and
  Current Market Trends (2018-2023)    5.2  
   Market Forecast (2024-2032)6   United States
  Neuromodulation Market - Breakup by Technology 
    6.1    Internal Neuromodulation        6.1.1
  Overview        6.1.2 Historical and Current
  Market Trends (2018-2023)        6.1.3 Market
  Segmentation           6.1.3.1 Spinal Cord
  Stimulation (SCS)           6.1.3.2 Deep Brain
  Stimulation (DBS)           6.1.3.3 Vagus Nerve
  Stimulation (VNS)           6.1.3.4 Sacral Nerve
  Stimulation (SNS)           6.1.3.5 Gastric
  Electrical Stimulation (GES)        6.1.4 Market
  Forecast (2024-2032)       

9
Table of Contents

•     6.2    External Neuromodulation        6.2.1
  Overview        6.2.2 Historical and Current
  Market Trends (2018-2023)        6.2.3 Market
  Segmentation           6.2.3.1 Transcutaneous
  Electrical Nerve Stimulation (TENS)         
   6.2.3.2 Transcranial Magnetic Stimulation
  (TMS)           6.2.3.3 Others        6.2.4
  Market Forecast (2024-2032)7   United States
  Neuromodulation Market - Breakup by Biomaterial 
    7.1    Metallic Biomaterials        7.1.1
  Overview        7.1.2 Historical and Current
  Market Trends (2018-2023)        7.1.3 Market
  Forecast (2024-2032)    7.2    Polymeric
  Biomaterials        7.2.1 Overview        7.2.2
  Historical and Current Market Trends
  (2018-2023)        7.2.3 Market Forecast
  (2024-2032)    7.3    Ceramic Biomaterials     
    7.3.1 Overview        7.3.2 Historical and
  Current Market Trends (2018-2023)        7.3.3
  Market Forecast (2024-2032)8   United States
  Neuromodulation Market - Breakup by Application 
    8.1    Parkinson's Disease        8.1.1
  Overview        8.1.2 Historical and Current
  Market Trends (2018-2023)        8.1.3 Market
  Forecast (2024-2032)
• For more information, visit https//www.imarcgrou
  p.com/united-states-neuromodulation-market/toc

10
Disclaimer

• 2023 IMARC All Rights Reserved
• This Publication and all its contents unless
  otherwise mentioned are copyrighted in the name
  of International Market Analysis Research and
  Consulting (IMARC). No part of this publication
  may be reproduced, repackaged, redistributed or
  resold in whole or in any part. The publication
  may also not be used in any form or by and means
  graphic electronic or mechanical, including
  photocopying, recording, taping or by information
  storage or retrieval, or by any other form,
  without the express consent of International
  Market Analysis Research and Consulting (IMARC).
• Disclaimer All contents and data of this
  publication, including forecasts, data analysis
  and opinion have been based on information and
  sources believed to be accurate and reliable at
  the time of publishing. International Market
  Analysis Research and Consulting makes no
  representation of warranty of any kind as to the
  accuracy or completeness of any Information
  provided. IMARC accepts no liability whatsoever
  for any loss or damage resulting from opinion,
  errors or inaccuracies if any found this
  publication.
• IMARC, IMARC Group and Global Therapy Insight
  Series are registered trademarks of International
  Market Analysis Research and Consulting. All
  other trademarks used in this publication are
  registered trademarks of their respective
  companies.

11
Contact Us
Visit us at
https//www.imarcgroup.com
TELEPHONE [phone] E-MAIL
sales_at_imarcgroup.com